Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer

• Published in: Scientific reports Vol. 11; no. 1; p. 24015
• Main Authors: Dulong, S., Huang, Q., Innominato, P. F., Karaboue, A., Bouchahda, M., Pruvost, A., Théodoro, F., Agrofoglio, L. A., Adam, R., Finkenstädt, B., Lévi, F.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 14.12.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67/1504/1885/1393; 692/308/53/2422; Adenosine; Cancer; Cancer therapies; Carcinoembryonic antigen; Chemotherapy; Circadian Rhythm; Circadian rhythms; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - mortality; Colorectal Neoplasms - urine; Disease-Free Survival; Excretion; Female; Humanities and Social Sciences; Humans; Male; Metastases; Metastasis; Middle Aged; multidisciplinary; Neoplasm Metastasis; Nucleic acids; Nucleosides; Nucleosides - urine; Patients; Science; Science (multidisciplinary); Survival Rate; Tumors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-03247-2

Urinary levels of modified nucleosides reflect nucleic acids turnover and can serve as non-invasive biomarkers for monitoring tumour circadian dynamics, and treatment responses in patients with metastatic colorectal cancer. In 39 patients, median overnight urinary excretion of LC-HRMS determinations of pseudouridine, was ~ tenfold as large as those of 1-methylguanosine, 1-methyladenosine, or 4-acetylcytidine, and ~ 100-fold as large as those of adenosine and cytidine. An increase in any nucleoside excretion after chemotherapy anticipated plasma carcinoembryonic antigen progression 1–2 months later and was associated with poor survival. Ten fractionated urines were collected over 2-days in 29 patients. The median value of the rhythm-adjusted mean of urinary nucleoside excretion varied from 64.3 for pseudouridine down to 0.61 for cytidine. The rhythm amplitudes relative to the 24-h mean of 6 nucleoside excretions were associated with rest duration, supporting a tight link between nucleosides turnover and the rest-activity rhythm. Moreover, the amplitude of the 1-methylguanosine rhythm was correlated with the rest-activity dichotomy index, a significant predictor of survival outcome in prior studies. In conclusion, urinary excretion dynamics of modified nucleosides appeared useful for the characterization of the circadian control of cellular proliferation and for tracking early responses to treatments in colorectal cancer patients.